Journal of Dermatology

Article	Citations
Vitiligo: A focus on pathogenesis and its therapeutic implications	116
Psoriasis: Comorbidities	91
Pathophysiology of psoriasis: A review	73
Development of a light‐weight deep learning model for cloud applications and remote diagnosis of skin cancers	69
Alopecia areata: Current understanding of the pathophysiology and update on therapeutic approaches, featuring the Japanese Dermatological Association guidelines	56
Psoriasis: Recent progress in molecular‐targeted therapies	45
Clinical characteristics and health‐care resource utilization in patients with generalized pustular psoriasis using real‐world evidence from the Japanese Medical Data Center database	38
Epidemiological survey of the psoriasis patients in the Japanese Society for Psoriasis Research from 2013 to 2018	36
Patient characteristics and burden of disease in Japanese patients with generalized pustular psoriasis: Results from the Medical Data Vision claims database	35
Epidemiological study of terbinafine‐resistant dermatophytes isolated from Japanese patients	34
The efficacy and safety of upadacitinib treatment for moderate to severe atopic dermatitis in real‐world practice in Japan	31
Real‐world effectiveness of guselkumab in patients with psoriasis: Health‐related quality of life and efficacy data from the noninterventional, prospective, German multicenter PERSIST trial	29
Clinical characteristics of Japanese pustular psoriasis: A multicenter observational study	27
Similarity and difference between palmoplantar pustulosis and pustular psoriasis	27
Role of necroptosis in infection‐related, immune‐mediated, and autoimmune skin diseases	26
Cutaneous manifestations of COVID‐19 and COVID‐19 vaccination	24
Efficacy of influential factors in hemoporfin‐mediated photodynamic therapy for facial port‐wine stains	23
Efficacy and safety of baricitinib treatment for moderate to severe atopic dermatitis in real‐world practice in Japan	23
Coronavirus disease 2019‐associated immunoglobulin A vasculitis/Henoch–Schönlein purpura: A case report and review	22
Successful treatment of Netherton syndrome with dupilumab: A case report and review of the literature	20
Treatment options for DOCK8 deficiency‐related severe dermatitis	20
Burden of illness, medication adherence, and unmet medical needs in Japanese patients with atopic dermatitis: A retrospective analysis of a cross‐sectional questionnaire survey	19
Stratum corneum levels of calprotectin proteins S100A8/A9 correlate with disease activity in psoriasis patients	19
Flare‐up of generalized pustular psoriasis combined with systemic capillary leak syndrome after coronavirus disease 2019 mRNA vaccination	19
Allergen‐specific immunotherapy induces monocyte‐derived dendritic cells but attenuates their maturation and cytokine production in the lesional skin of an atopic dermatitis mous	19

Case of bullous pemphigoid following coronavirus disease 2019 vaccination	18
Treatment of bullous pemphigoid with dupilumab: Dupilumab exerts its effect by primarily suppressing T‐helper 2 cytokines	18
Psoriasis exacerbation after first dose of AstraZeneca coronavirus disease 2019 vaccine	17
Pathogenesis of cutaneous T cell lymphoma: Involvement of Staphylococcus aureus	17
Safety considerations of systemic Janus kinase inhibitors in atopic dermatitis applications	17
Teledermatology in times of COVID‐19	17
Real‐world effectiveness and safety of baricitinib in Japanese patients with atopic dermatitis: A single‐center retrospective study	17
SERPINA1, generalized pustular psoriasis, and adult‐onset immunodeficiency	16
Outlines of the Japanese guidelines for the management of primary cutaneous lymphomas 2020	16
Efficacy and safety of risankizumab in Japanese patients with generalized pustular psoriasis or erythrodermic psoriasis: Primary analysis and 180‐week follow‐up results from the phase 3, multicenter <	16
Five‐year survival with nivolumab in previously untreated Japanese patients with advanced or recurrent malignant melanoma	16
Clinical analysis of generalized pustular psoriasis in Chinese patients: A retrospective study of 110 patients	16
Fulminant type 1 diabetes mellitus triggered by coronavirus disease 2019 vaccination in an advanced melanoma patient given adjuvant nivolumab therapy	16
Neurogenic rosacea in Korea	15
Merkel cell carcinoma: A systematic review of the demographic and clinical characteristics of 847 cases in Japan	15
The first case of monkeypox virus and acute HIV infection: Should we consider monkeypox a new possible sexually transmitted infection?	15
Efficacy and safety of topical Janus kinase and phosphodiesterase inhibitor‐4 inhibitors for the treatment of atopic dermatitis: A network meta‐analysis	15
Rhododendrol‐induced leukoderma update I: Clinical findings and treatment	15
Comprehensive stratum corneum ceramide profiling reveals reduced acylceramides in ichthyosis patient with CERS3 mutations	15
Which factors influence Demodex proliferation? A retrospective pilot study highlighting a possible role of subtle immune variations and sebaceous gland status	15
Real‐world, long‐term treatment patterns of commonly used biologics in Canadian patients with moderate‐to‐severe chronic plaque psoriasis	15
Emerging insights into the immunological aspects of keloids	15
Gut microbiome profile in psoriatic patients treated and untreated with biologic therapy	15
Current treatments for atopic dermatitis in Japan	14
Lichen planus‐like lesion preceding bullous pemphigoid development after programmed cell death protein‐1 inhibitor treatment	14
Long‐standing refractory hidradenitis suppurativa responded to a brodalumab monotherapy in a patient with psoriasis: A possible involvement of Th17 across the spectrum of both diseases	14
Early add‐on administration of mepolizumab and intravenous immunoglobulin effective in treating eosinophilic granulomatosis with polyangiitis	14
Durable remission after rechallenge with ipilimumab and nivolumab in metastatic Merkel cell carcinoma refractory to avelumab: Any role for sequential immunotherapy?	14
Dermoscopic features of nail psoriasis: Positive correlation with the severity of psoriasis	14
Significance of IL36RN mutation analyses in the management of impetigo herpetiformis: A case report and review of published cases	14
Autophagy in skin barrier and immune‐related skin diseases	14
Clinical significance of the water retention and barrier function‐improving capabilities of ceramide‐containing formulations: A qualitative review	14
Efficacy and safety of spesolimab in Asian patients with a generalized pustular psoriasis flare: Results from the randomized, double‐blind, placebo‐controlled Effisayil™ 1 study	14
Cutaneous eruption in COVID‐19‐infected patients in Thailand: An observational descriptive study	14
Update on trichoscopy: Integration of the terminology by systematic approach and a proposal of a diagnostic flowchart	13
A phase 3, multicenter, randomized, double‐blind, vehicle‐controlled, parallel‐group study of 5% sofpironium bromide (BBI‐4000) gel in Japanese patients with primary axillary hyperhidrosis	13
Sustained efficacy and safety of guselkumab in patients with palmoplantar pustulosis through 1.5 years in a randomized phase 3 study	13
English version of Japanese guidance for use of biologics for psoriasis (the 2022 version)	13
Psoriatic arthritis	13
Efficacy and safety of brodalumab in the Korean population for the treatment of moderate to severe plaque psoriasis: A randomized, phase III, double‐blind, placebo‐controlled study	13
Incidental amelioration of bullous pemphigoid during ixekizumab treatment for psoriasis	13
Prevalence, comorbidities, and treatment patterns of Japanese patients with alopecia areata: A descriptive study using Japan medical data center claims database	13
Care for children with atopic dermatitis in the Netherlands during the COVID‐19 pandemic: Lessons from the first wave and implications for the future	13
Neutrophil : lymphocyte ratio is associated with disease severity and mortality in patients with Stevens–Johnson syndrome/toxic epidermal necrolysis	13
Real‐world prevalence and burden of genital eczema in atopic dermatitis: A multicenter questionnaire‐based study	12
Various skin manifestations related to inflammatory bowel disease: A nationwide cross‐sectional study on the Korean population	12
Update of recent findings in genetic hair disorders	12
Adalimumab in Japanese patients with active ulcers of pyoderma gangrenosum: Final analysis of a 52‐week phase 3 open‐label study	12
Efficacy and safety of the selective TYK2 inhibitor, deucravacitinib, in Japanese patients with moderate to severe plaque psoriasis: Subgroup analysis of a randomized, double‐blind, placebo	12
Excellent response to secukinumab in an infant with severe generalized pustular psoriasis	12

English Version of Clinical Practice Guidelines for the Management of Atopic Dermatitis 2021	12
A homozygous loss‐of‐function variant in the MPO gene is associated with generalized pustular psoriasis	12
Impairment of autophagy may be associated with follicular miniaturization in androgenetic alopecia by inducing premature catagen	12
What's new in the pathogeneses and triggering factors of bullous pemphigoid	12
Establishment of the Western Japan Psoriasis Registry and first cross‐sectional analysis of registered patients	12
Nail involvement features in palmoplantar pustulosis	11
Clinical guidance of pyoderma gangrenosum 2022	11
Three cases of drug‐induced hypersensitivity syndrome associated with mRNA‐based coronavirus disease 2019 vaccines	11
Surgical procedures and innovative approaches for vitiligo regenerative treatment and melanocytorrhagy	11
Safety, efficacy, and drug survival of the infliximab biosimilar CT‐P13 in post‐marketing surveillance of Japanese patients with psoriasis	11
Epidemiology and clinical features of pustular psoriasis: A 15‐year retrospective cohort	11
Rhododendrol‐induced leukoderma update II: Pathophysiology, mechanisms, risk evaluation, and possible mechanism‐based treatments in comparison with vitiligo	11
Epidemiology of hidradenitis suppurativa in Taiwan: A 14‐year nationwide population‐based study	11
Health‐related quality of life in patients with alopecia areata: Results of a Japanese survey with norm‐based comparisons	11
Dipeptidyl peptidase‐4 inhibitor‐related bullous pemphigoid: A comparative study of 100 patients with bullous pemphigoid and diabetes mellitus	11
Fetal–neonatal and maternal outcomes in women with psoriasis vulgaris: A nationwide population‐based registry linkage study in Taiwan	11
Psychological burden of psoriatic patients in a German university hospital dermatology department	11
Successful treatment of epidermolysis bullosa pruriginosa by dupilumab	11
Efficacy and safety of i.v. methylprednisolone pulse therapy for vitiligo: A retrospective study of 58 therapy experiences for 33 vitiligo patients	11
Perspectives on rosacea patient characteristics and quality of life using baseline data from a phase 3 clinical study conducted in Japan	10
Comparison of efficacy and safety of corticosteroid and vincristine in treating kaposiform hemangioendothelioma and tufted angioma: A multicenter prospective randomized controlled clinical trial	10
Possible involvement of zinc deficiency in epidermal growth factor receptor inhibitor‐induced xerotic dermatitis	10
Arthritis and enthesitis during dupilumab therapy completely remitted by celecoxib	10
Novel mutations in Chinese hypotrichosis simplex patients associated with LSS gene	10
Mechanisms of ultraviolet‐induced melasma formation: A review	10
Leukocytoclastic vasculitis after coronavirus disease 2019 vaccination	10
Management of hair loss after severe acute respiratory syndrome coronavirus 2 infection: Insight into the pathophysiology with implication for better management	10
Indirect consequences of coronavirus disease 2019: Skin lesions caused by the frequent hand sanitation and use of personal protective equipment and strategies for their prevention	10
Is blocking IL‐4 receptor alpha beneficial for patients with mycosis fungoides or Sézary syndrome?	10
Case of immunoglobulin A vasculitis following coronavirus disease 2019 vaccination	10
Treatment patterns, healthcare resource utilization, and costs in patients with moderate‐to‐severe psoriasis treated with systemic therapy in Japan: A retrospective claims database study	10
Interferon‐α activates interleukin‐1 receptor‐associated kinase 1 to induce regulatory T‐cell apoptosis in patients with systemic lupus erythematosus	10
A phase III, 52‐week, open‐label study to evaluate the safety and efficacy of 5% sofpironium bromide (BBI‐4000) gel in Japanese patients with primary axillary hyperhidrosis	10
Thiamidol® in moderate‐to‐severe melasma: 24‐week, randomized, double‐blind, vehicle‐controlled clinical study with subsequent regression phase	10
Development of a scoring system to predict outcomes of i.v. corticosteroid pulse therapy in rapidly progressive alopecia areata adopting digital image analysis of hair recovery	10
Five cases of new‐onset pemphigus following vaccinations against coronavirus disease 2019	10
Oxford‐AstraZeneca COVID‐19 vaccine‐induced acute localized exanthematous pustulosis	10
Characterization of EDARADD gene mutations responsible for hypohidrotic ectodermal dysplasia	9
Uptake of Staphylococcus aureus by keratinocytes is reduced by interferon–fibronectin pathway and filaggrin expression	9
Tick bites in Japan	9
Clinical practice guidelines for pseudoxanthoma elasticum (2017)	9
Japanese Dermatological Association Guidelines: Outlines of Guidelines for Cutaneous Squamous Cell Carcinoma 2020	9
Immunoglobulin A vasculitis post‐severe acute respiratory syndrome coronavirus 2 vaccination and review of reported cases	9
Increased prevalence of doxycycline low‐susceptible Cutibacterium acnes isolated from acne patients in Japan caused by antimicrobial use and diversification of tetracycline resistance factors	9
Patched 1 expression in Merkel cell carcinoma	9
Retrospective analysis of the clinical characteristics and patient‐reported outcomes in vulval lichen planus: Results from a single‐center study	9
Epidemiological survey of patients with pustular psoriasis in the Japanese Society for Psoriasis Research from 2017 to 2020	9
Prevalence and presumptive triggers of localized bullous pemphigoid	9
Updated analysis of nivolumab and ipilimumab combination therapy in Japanese patients with advanced melanoma	9
Association between psoriasis and alopecia areata: A systematic review and meta‐analysis	9
25‐Hydroxyvitamin D serum levels inversely correlate to disease severity and serum C‐reactive protein levels in patients with hidradenitis suppurativa	9
Flare‐up of generalized pustular psoriasis following Pfizer‐BioNTech BNT162b2 mRNA COVID‐19 vaccine: Two cases without mutations of IL36RN and CARD14 gen	9
Two cases of severe congenital hypotrichosis caused by compound heterozygous mutations in the LSS gene	9
Real‐world data on the use of secukinumab and acitretin in pediatric generalized pustular psoriasis	9
Invasive and in situ lesions of squamous cell carcinoma are independent factors for postoperative surgical‐site infection after outpatient skin tumors surgery: A retrospective study of 512 pati	9
Primary cicatricial alopecia: Recent advances in evaluation and diagnosis based on trichoscopic and histopathological observation, including overlapping and specific features	9
Therapeutic effectiveness of upadacitinib on individual types of rash in Japanese patients with moderate‐to‐severe atopic dermatitis	9
Validation of a lateral flow immunochromatographic assay for tinea unguium diagnosis	8
Increased serum levels of CCL3, CXCL8, CXCL9, and CXCL10 in rosacea patients and their correlation with disease severity	8
Background factors predicting the occurrence of herpes zoster in atopic dermatitis patients treated with upadacitinib	8
Ultraviolet A rush hardening for chronic actinic dermatitis: Pilot treatment outcomes	8
Case of acquired reactive perforating collagenosis induced by panitumumab for colon cancer	8
Endoplasmic reticulum stress and collagenous formation anomalies in vascular‐type Ehlers–Danlos syndrome via electron microscopy	8
The first Hermansky–Pudlak syndrome type 9 patient with two novel variants in Chinese population	8
Prognosis after steroid pulse therapy and seasonal effect in acquired idiopathic generalized anhidrosis	8
Uncovering the unmet needs among psoriasis patients in the Asia‐Pacific region	8
Annular plaques mimicking Rowell’s syndrome in the course of coronavirus disease 2019 mRNA vaccines: An overlooked phenomenon?	8
Real‐world safety and effectiveness of adalimumab in patients with hidradenitis suppurativa: 12‐week interim analysis of post‐marketing surveillance in Japan	8
Super‐resolution imaging detects BP180 autoantigen in immunoglobulin M pemphigoid	8
Prevalence of alopecia areata in Japan: Estimates from a nationally representative sample	8
Adult‐onset immunodeficiency due to anti‐interferon‐gamma autoantibody‐associated Sweet syndrome: A distinctive entity	8
Overlapping acute generalized exanthematous pustulosis drug reaction with eosinophilia and systemic symptoms induced by a second dose of the Moderna COVID‐19 vaccine	8
Role of pro‐inflammatory cytokines in the pathophysiology of herpes simplex virus superinfection in Darier’s disease	8
Biologics modulate antinuclear antibodies, immunoglobulin E, and eosinophil counts in psoriasis patients	8
Metronidazole gel (0.75%) in Japanese patients with rosacea: A randomized, vehicle‐controlled, phase 3 study	8
De novo guttate psoriasis following coronavirus disease 2019 vaccination	8
Clinical outcomes in adult patients with plaque psoriasis treated with ustekinumab under real‐world practice in Korea: A prospective, observational, multi‐center, postmarketing surveillance study	8
Baricitinib improved alopecia areata concomitant with atopic dermatitis: A case report	8
Dupilumab‐associated cutaneous adverse events among adult patients with atopic dermatitis: A retrospective study	8
Deep cutaneous fungal infection by Pleosporales: An exceptional pathogen in tropical Taiwan	8

Risk of retinal diseases in patients with psoriasis: A population‐based cohort study in Taiwan	8
A phase 2b, randomized, double‐blind, multicenter, vehicle‐controlled study to assess the efficacy and safety of two crisaborole regimens in Japanese patients aged 2 years and older with mild‐to‐moder	8
Characteristic nail lesions in Kawasaki disease: Case series and literature review	7
Association between vitiligo and subsequent risk of dementia: A population‐based cohort study	7
Granuloma annulare triggered by SARS‐CoV‐2 infection. The first reported case	7
A case of persistent, confluent maculopapular erythema following a COVID‐19 mRNA vaccination is possibly associated with the intralesional spike protein expressed by vascular end	7
Rare cases of PAMI syndrome in both father and son with the same missense mutation in PSTPIP1 gene and literature review	7
Erythema nodosum‐like eruption in coronavirus disease 2019: A case report and literature review of Asian countries	7
Lichen planus pemphigoides with antibodies against the BP180 C‐terminal domain induced by pembrolizumab in a melanoma patient	7
Case series of BRAF‐mutated advanced melanoma treated with encorafenib plus binimetinib combination therapy	7
Refractory serum immunoglobulin M elevation during anti‐interleukin (IL)‐1‐ or IL‐6‐targeted treatment in four patients with Schnitzler syndrome	7
Two cases of Hailey‐Hailey disease effectively treated with apremilast and a review of reported cases	7
Sweet syndrome after severe acute respiratory syndrome coronavirus 2 mRNA vaccine: A case report and literature review	7
Safety and efficacy of bexarotene for Japanese patients with cutaneous T‐cell lymphoma: Real‐world experience from post‐marketing surveillance	7
Recent advances in cutaneous HPV infection	7
Risk of psychiatric diseases among patients with psoriasis in Korea: A 12‐year nationwide population‐based cohort study	7
Exacerbation of systemic lupus erythematosus after receiving mRNA‐1273‐based coronavirus disease 2019 vaccine	7
Allergic contact stomatitis due to desensitizing toothpastes	7
Predictors for readmission due to cellulitis among Japanese patients	7
Clinical features and outcomes in children with Stevens–Johnson syndrome and toxic epidermal necrolysis	7
Topical glycopyrronium tosylate in Japanese patients with primary axillary hyperhidrosis: A randomized, double‐blind, vehicle‐controlled study	7
Dupilumab shows slow, steady effectiveness for intractable prurigo in patients with atopic dermatitis	7
Association between hepatitis C virus infection and subsequent chronic inflammatory skin disease	7
Work ability and quality of working life in atopic dermatitis patients treated with dupilumab	7
Ixekizumab successfully treated refractory psoriasis concurrent bullous pemphigoid	7
Efficacy and safety of crisaborole ointment in Chinese and Japanese patients aged ≥2 years with mild‐to‐moderate atopic dermatitis	7
Safety and effectiveness of nivolumab in Japanese patients with malignant melanoma: Final analysis of a post‐marketing surveillance	7
Sirolimus for the treatment of kaposiform hemangioendothelioma: In a trough level‐dependent way	7
Percentage of residual B cells after 2 weeks of rituximab treatment predicts the improvement of systemic sclerosis‐associated interstitial lung disease	7
Practical algorithm to inform clinical decision‐making in the topical treatment of atopic dermatitis	7
Epidemiological study of antifungal‐resistant dermatophytes isolated from Japanese patients	7
Patient and physician perspectives on alopecia areata: A real‐world assessment of severity and burden in Japan	7
Possible roles of CXCL13/CXCR5 axis in the development of bullous pemphigoid	6
The genetic and epigenetic basis of distinct melanoma types	6
Apremilast improves quality of life and ultrasonography parameters in patients with nail psoriasis: A prospective cohort study	6
Elevated interleukin‐11 in systemic sclerosis and role in disease pathogenesis	6
Severe cutaneous adverse reactions associated with systemic ivermectin: A pharmacovigilance analysis	6
Expanding mutational spectrum of HRAS by a patient with Schimmelpenning–Feuerstein–Mims syndrome	6
Long‐term safety of combination treatment with methotrexate and tumor necrosis factor (TNF)‐α antagonists versus TNF‐α antagonists alone in psoriatic patients	6
Dipeptidyl peptidase 4 inhibitor‐associated mucous membrane pemphigoid	6
A phase 3, randomized, double‐blind, placebo‐controlled study evaluating a single, patient‐initiated dose of amenamevir for recurrent herpes labialis	6
Managing chromoblastomycosis with acitretin plus imiquimod: A case report on the improvement of cutaneous lesions and reduction of the treatment time	6
Dissolving microneedles for effective and painless intradermal drug delivery in various skin conditions: A systematic review	6
Filaggrin‐gene mutation has minimal effect on the disease severity in the lesions of atopic dermatitis	6
Erythropoietic protoporphyria in the Netherlands: Clinical features, psychosocial impact and the effect of afamelanotide	6
Efficacy of a moisturizer for pruritus accompanied by xerosis in patients undergoing dialysis: A multicenter, open‐label, randomized verification study	6
Severe skin inflammation leads to salivary gland atrophy and dysfunction	6
Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in Japanese patients with moderate to severe plaque, erythrodermic, or generalized pustular psoriasis: Efficacy and safety	6
Clinical characteristics of patients with psoriasis with family history: A multicenter observational study	6
Adverse effects of trimethoprim–sulfamethoxazole for the prophylaxis of Pneumocystis pneumonia in dermatology	6
T cell autoimmunity and immune regulation to desmoglein 3, a pemphigus autoantigen	6
Health‐related quality of life in patients with neurofibromatosis 1 in Japan: A questionnaire survey using EQ‐5D‐5L	6
Issue Information	6
Work productivity in real‐life employed patients with plaque psoriasis: Results from the ProLOGUE study	6
Efficacy of oral JAK1 or JAK1/2 inhibitor for treating refractory pruritus in dystrophic epidermolysis bullosa: A retrospective case series	6
Skin ulcer at the injection site of BNT162b2 mRNA COVID‐19 vaccine	6
Impact of daily wearing of fabric gloves on the management of hand eczema: A pilot study in health‐care workers	6
Mycosis fungoides and Sézary syndrome tumor cells express epidermal fatty acid‐binding protein, whose expression decreases with loss of epidermotropism	6
Increased touch‐evoked itch (punctate hyperknesis) in postherpetic itch: Implications of reduced intraepidermal nerve fibers representing small fiber neuropathy	6
Cutaneous manifestations of coronavirus disease 2019 patients in Japan	6
Evidence for a dominant‐negative effect of a missense mutation in the SERPING1 gene responsible for hereditary angioedema type I	6
Analysis of clonality in cutaneous B‐cell lymphoma and B‐cell pseudolymphoma using skin flow cytometry: Comparison of immunophenotyping and gene rearrangement studies	6
Development of toxic epidermal necrolysis in a coronavirus disease 2019 patient with recurrence of positive SARS‐CoV‐2 viral RNA	6
Broad spectrum in vitro microbicidal activity of benzoyl peroxide against microorganisms related to cutaneous diseases	6
The Pharmacist's role in dermatology: Patient medication adherence	6
Improvement of acyclovir‐resistant herpes zoster infection by amenamevir	6
A case of non‐uremic calciphylaxis associated with systemic lupus erythematosus and antiphospholipid syndrome	6
Possible role of epiregulin from dermal fibroblasts in the keratinocyte hyperproliferation of psoriasis	6
Tumor lysis syndrome induced by BRAF/MEK double blockade in a patient with metastatic melanoma: A first case report	6
Case of atopic eczema treated with dupilumab throughout conception, pregnancy, and lactation	6
Biomarkers of endothelial dysfunction and atherosclerosis in hidradenitis suppurativa	6
Clinical effectiveness of efinaconazole 10% solution for treatment of onychomycosis with longitudinal spikes	6
Normolipemic xanthomatized Sweet’s syndrome: A variant of Sweet’s syndrome with myelodysplastic syndrome	6
Hyperhidrosis: A targeted literature review of the disease burden	6
Vulvar hidradenitis suppurativa: Clinical cross‐sectional study of 25 patients	6
Long‐term efficacy and safety of tildrakizumab in Japanese patients with moderate to severe plaque psoriasis: Results from a 5‐year extension of a phase 3 study (reSURFACE 1)	6
Basaloid follicular hamartomas in pediatric Basal Cell Nevus Syndrome: A diagnostic challenge	6
2020 guidelines for the diagnosis and treatment of cutaneous pruritus	6
Dupilumab‐induced skin‐associated side effects in patients with chronic rhinosinusitis with nasal polyposis	6
Efficacy of bath‐psoralen and ultraviolet A therapy for mycosis fungoides – retrospective analysis of 62 cases	5
Psoriasis in the geriatric population: A retrospective study in Asians	5
Genetic analyses of a secondary poroma and trichoblastoma in a HRAS‐mutated sebaceous nevus	5
Histopathological analysis of skin reactions after coronavirus disease 2019 vaccination: Increment in number of infiltrated plasmacytoid dendritic cell	5
Perifolliculitis capitis abscedens et suffodiens with hidradenitis suppurativa and nodulocystic acne treated with adalimumab	5
Generalized multinucleate cell angiohistiocytoma with possible origin from fibroblasts: A clinicopathological study of 15 cases	5
Comorbid anxiety and depression among black women with central centrifugal cicatricial alopecia: A retrospective study	5
Anti‐phosphatidylserine/prothrombin complex antibodies in patients with cutaneous vasculitis: Possible involvement in the pathogenesis	5
Treatment of intra‐anal warts with imiquimod 5% cream: A single‐center prospective open study	5
Genetic mutations in pyoderma gangrenosum, hidradenitis suppurativa, and associated autoinflammatory syndromes: Insights into pathogenic mechanisms and shared pathways	5
Serum levels of angiogenesis‐related factors in patients with psoriasis	5
A case of VEXAS syndrome with myositis possibly associated with macrophage activation syndrome	5
The effectiveness and safety of dupilumab in the management of refractory prurigo nodularis in 45 Chinese patients: A real‐life observational study	5
Novel pathogenic variants in the RECQL4 gene causing Rothmund‐Thomson syndrome in three Chinese patients	5
A case of VEXAS syndrome with Sweet's disease and pulmonary involvement	5
A prospective, phase II study on the safety and efficacy of negative pressure closure for the stabilization of split‐thickness skin graft in large or muscle‐exposing defects: The NPSG study	5